Key result
IL-4 and IL-10 increase IL-8 release ~3-fold in LPS-stimulated HUVECs.
Answers are grounded in this paper and cite their sources.
The aim of this study was to determine the effect of interleukin-4 (IL-4) and interleukin-10 (IL-10) on interleukin-8 (IL-8) release from endothelial cells. Confluent monolayers of human umbilical vein endothelial cells (HUVECs) were incubated in the absence or presence of 10 ng/ml of bacterial lipopolysaccharide (LPS), with 5% human AB serum and recombinant human IL-4 or IL-10 over a dose range from 50 fg/ml to 50 ng/ml (final concentration). IL-4 and IL-10 had no effect on HUVEC IL-8 release in the absence of LPS. In the presence of LPS, IL-4 and IL-10 enhanced IL-8 release by approximately 300% compared with LPS-stimulated cells alone, IL-8 release increasing from 2594 +/- 493 pg/ml (no IL-4 or IL-10) to 7892 +/- 320 pg/ml (IL-4, 5 pg/ml; p = 0.001) and 8359 +/- 712 pg/ml (IL-10, 50 pg/ml; p = 0.002). IL-8 release in response to IL-4 or IL-10 plateaued above 5 and 50 pg/ml, respectively. This study suggests that IL-4 and IL-10 may be involved in the complex regulation of endothelial cell cytokine production during the response to endotoxin.
No takes yet. Share an insight, caveat, or question.
Beaux et al. (1995) studied Endotoxin-stimulated endothelial cell response. Recombinant human Interleukin-4 (IL-4) or Interleukin-10 (IL-10) vs. LPS-stimulated cells alone (no IL-4 or IL-10) was evaluated on Interleukin-8 (IL-8) release (pg/ml) (p=0.001). Recombinant human IL-4 and IL-10 enhanced IL-8 release by ~300% in LPS-stimulated HUVECs compared with LPS alone (p=0.001 and p=0.002).
Synapse has enriched 10 related papers. Consider them for comparative context: